In high-grade ovarian cancers, nearly 70% of all cases have hyperactivation of PI3K signaling pathway, high iNOS expression is predominant in these tumors and may be associated with resistance to platinum-based chemotherapies and enhanced metastatic capacity mediated by EMT43–45. Here, NOS2 is linked to ovarian cancer.